The potential benefits of GLP-1s include: Weight loss Obesity management Reduced cravings or food noise Improved lipid disorders Improved fatty liver disease Reduced risk of kidney disease Delayed progression of diabetes-related nephropathy Reduced risk of cardiovascular disease (CVD) Lower risk of stroke Ongoing studies are exploring the effectiveness of GLP-1 medications for other conditions, such as polycystic ovary syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD)
Tirzepatide, a dual GIP/GLP-1 receptor agonist, slows gastric emptying and modulates insulin secretion through incretin hormone pathways
The company is also planning to launch a pen device, likely in April, priced at 4,000 4,500 monthly
#DidYouKnow #Chemotherapy #OncologyNursing #SafetyStandards To view or add a comment, sign in Our study on lisinopril showed that the branded drug was superior to two generic formulations in reducing systolic blood pressure in rats over two weeks, with no significant impact on liver and cardiac enzymes, and greater safety for kidney and heart function
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer
The study conducted by Zhang et al
